velscope presentation (short)
TRANSCRIPT
![Page 1: Velscope Presentation (Short)](https://reader030.vdocument.in/reader030/viewer/2022032616/55a762841a28ab29058b457a/html5/thumbnails/1.jpg)
![Page 2: Velscope Presentation (Short)](https://reader030.vdocument.in/reader030/viewer/2022032616/55a762841a28ab29058b457a/html5/thumbnails/2.jpg)
3
DETECT THE EARLIEST CHANGES
![Page 3: Velscope Presentation (Short)](https://reader030.vdocument.in/reader030/viewer/2022032616/55a762841a28ab29058b457a/html5/thumbnails/3.jpg)
7Image courtesy of the British Columbia Oral Cancer Prevention Program
Patient DPatient D
Abnormal Tissue?
![Page 4: Velscope Presentation (Short)](https://reader030.vdocument.in/reader030/viewer/2022032616/55a762841a28ab29058b457a/html5/thumbnails/4.jpg)
8Images courtesy of the British Columbia Oral Cancer Prevention Program
Patient DPatient D
Clinical Appearance
Irregular, Dark Area
Biopsy confirmed Carcinoma in situ
![Page 5: Velscope Presentation (Short)](https://reader030.vdocument.in/reader030/viewer/2022032616/55a762841a28ab29058b457a/html5/thumbnails/5.jpg)
9Image courtesy of the British Columbia Oral Cancer Prevention Program
Patient EPatient E
Where Is The Abnormal Tissue?
Polyp
![Page 6: Velscope Presentation (Short)](https://reader030.vdocument.in/reader030/viewer/2022032616/55a762841a28ab29058b457a/html5/thumbnails/6.jpg)
10
Mild dysplasia
CIS
Clinical Appearance
Suspicious region is now clearly visible. Confirmed CIS.
Polyp
Images courtesy of the British Columbia Oral Cancer Prevention Program
Patient EPatient E (continued)(continued)
Polyp(white)
![Page 7: Velscope Presentation (Short)](https://reader030.vdocument.in/reader030/viewer/2022032616/55a762841a28ab29058b457a/html5/thumbnails/7.jpg)
11
Oral Lesions May Show as
Irregular, Dark Areas
Images courtesy of the British Columbia Oral Cancer Prevention Program
Observe or Refer?
Severe Dysplasia
![Page 8: Velscope Presentation (Short)](https://reader030.vdocument.in/reader030/viewer/2022032616/55a762841a28ab29058b457a/html5/thumbnails/8.jpg)
12
An Oral Lesion that Shows No Change in Autofluorescence
Appearing Pale Green
Images courtesy of the British Columbia Oral Cancer Prevention Program
Hyperplasia
Observe or Refer?
![Page 9: Velscope Presentation (Short)](https://reader030.vdocument.in/reader030/viewer/2022032616/55a762841a28ab29058b457a/html5/thumbnails/9.jpg)
14
Pre-clinical discovery
Left palate : low-grade mucoepidermoid carcinoma
![Page 10: Velscope Presentation (Short)](https://reader030.vdocument.in/reader030/viewer/2022032616/55a762841a28ab29058b457a/html5/thumbnails/10.jpg)
15
EXTENSIVE CLINICAL SUPPORT
10+ Years of Research in the Oral Cavity
• 2009 General Dentistry – K. Huff, et al• 2007 Head & Neck – P.M. Williams, et al.• 2006 Clinical Cancer Research – C.F. Poh, et al• 2005 Oral Oncology – deVeld, et al.
Proven Efficacywww.VELscope.com/research
![Page 11: Velscope Presentation (Short)](https://reader030.vdocument.in/reader030/viewer/2022032616/55a762841a28ab29058b457a/html5/thumbnails/11.jpg)
16
Reimbursement Code (US)
D0431
Adjunctive Mucosal ScreeningAdjunctive Mucosal ScreeningAn adjunctive pre-diagnostic test
that aids in detection of mucosal abnormalities including
pre-malignant and malignant lesions.Not to include cytology or biopsy.
Note: This reimbursement code is only valid in the U.S. and it will be different for other countries.